Image_2_Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma.tif
It has been shown that aberrant activation of the Hedgehog (Hh) and nuclear factor-kappa B (NF-κB) signaling pathways plays an important role in the pancreatic carcinogenesis, and KRAS mutation is a hallmark of pancreatic ductal adenocarcinoma (PDAC). Until now, the role of KRAS mutation in the context of crosstalk between Hh and NF-κB signaling pathways in PDAC has not been investigated. This study was to determine whether the crosstalk between the Hh and NF-κB pathways is dependent on KRAS mutation in PDAC. The correlation between Gli1, Shh, NF-κB p65 expression and KRAS mutation in PDAC tissues was firstly examined by immunohistochemistry. Next, Western blotting, qPCR, and immunofluorescence were conducted to examine the biological effects of interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α) as NF-κB signaling agonists, Shh as an Hh ligand alone or in combination with KRAS small interfering RNA (si-KRAS) in KRAS-mutant PDAC cells (MT-KRAS; SW1990 and Panc-1), wild-type KRAS PDAC cells (WT-KRAS; BxPC-3) and mutant KRAS knock-in BxPC-3 cells in vitro as well as tumor growth in vivo. KRAS mutation-dependent crosstalk between Hh and NF-κB in PDAC cells was further assessed by Ras activity and luciferase reporter assays. The aberrant Hh and NF-κB pathway activation was found in PDAC tissues with KRAS mutation. The same findings were confirmed in MT-KRAS PDAC cells and MT-KRAS knock-in BxPC-3 cells, whereas this activation was not observed in WT-KRAS PDAC cells. However, the activation was significantly down-regulated by KRAS silencing in MT-KRAS PDAC cells. Furthermore, MT-KRAS cancer cell proliferation and survival in vitro and tumor growth after inoculation with MT-KRAS cells in vivo were promoted by NF-κB and Hh signaling activation. The pivotal factor for co-activation of NF-κB and Hh signaling is MT-KRAS protein upregulation, showing that positive crosstalk between Hh and NF-κB pathways is dependent upon KRAS mutation in PDAC.
History
References
- https://doi.org//10.3322/caac.21590
- https://doi.org//10.1007/978-1-4939-7193-0_5
- https://doi.org//10.1126/science.1164368
- https://doi.org//10.1136/gut.2010.236026
- https://doi.org//10.3892/ol.2019.10041
- https://doi.org//10.1158/0008-5472.CAN-05-4588
- https://doi.org//10.1038/nature25459
- https://doi.org//10.1038/287795a0
- https://doi.org//10.1002/jcp.26506
- https://doi.org//10.7150/jca.15786
- https://doi.org//10.1002/ijc.28424
- https://doi.org//10.6092/1590-8577/2894
- https://doi.org//10.3390/cells8020153
- https://doi.org//10.1074/jbc.RA119.007956
- https://doi.org//10.1038/s41419-019-1776-x
- https://doi.org//10.1051/medsci/20132911015
- https://doi.org//10.1053/j.gastro.2013.07.025
- https://doi.org//10.1158/2159-8290.CD-13-0593
- https://doi.org//10.1053/j.gastro.2014.08.002
- https://doi.org//10.1038/s41388-019-0718-5
- https://doi.org//10.1016/j.ccr.2007.01.012
- https://doi.org//10.1016/j.jcmgh.2017.05.005
- https://doi.org//10.1158/2159-8290.CD-19-0297
- https://doi.org//10.1136/gutjnl-2011-301008
- https://doi.org//10.1038/s41416-019-0595-2
- https://doi.org//10.1007/978-1-4939-8879-2_25
- https://doi.org//10.1371/journal.pone.0068891
- https://doi.org//10.4049/jimmunol.1202286
- https://doi.org//10.1016/0014-5793(96)00690-4
- https://doi.org//10.1158/1535-7163.MCT-08-0924
- https://doi.org//10.1007/s10549-009-0617-5
- https://doi.org//10.2353/ajpath.2010.090810
- https://doi.org//10.1158/1078-0432.CCR-10-3376
- https://doi.org//10.1073/pnas.1114168109
- https://doi.org//10.1038/nrgastro.2012.115
- https://doi.org//10.1074/jbc.M112.432302